Outset Medical Inc [NASDAQ: OM] stock went on an upward path that rose over 25.18% on Thursday, amounting to a one-week price increase of more than 36.16%.
Over the last 12 months, OM stock dropped by -81.99%. The one-year Outset Medical Inc stock forecast points to a potential upside of 73.01. The average equity rating for OM stock is currently 2.25, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $40.43 million, with 50.32 million shares outstanding and 47.80 million shares in the current float. Compared to the average trading volume of 1.90M shares, OM stock reached a trading volume of 5170272 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Outset Medical Inc [OM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for OM shares is $2.89 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OM stock is a recommendation set at 2.25. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
RBC Capital Mkts have made an estimate for Outset Medical Inc shares, keeping their opinion on the stock as Sector Perform, with their previous recommendation back on August 08, 2024. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price from $5 to $6. The new note on the price target was released on June 21, 2024, representing the official price target for Outset Medical Inc stock. Previously, the target price had yet another raise to $6, while BTIG Research analysts kept a Buy rating on OM stock.
The Average True Range (ATR) for Outset Medical Inc is set at 0.07, with the Price to Sales ratio for OM stock in the period of the last 12 months amounting to 0.35. The Price to Book ratio for the last quarter was 0.85, with the Price to Cash per share for the same quarter was set at 3.37.
OM Stock Performance Analysis:
Outset Medical Inc [OM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 36.16. With this latest performance, OM shares gained by 23.23% in over the last four-week period, additionally sinking by -76.27% over the last 6 months – not to mention a drop of -81.99% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OM stock in for the last two-week period is set at 68.19, with the RSI for the last a single of trading hit 81.85, and the three-weeks RSI is set at 54.58 for Outset Medical Inc [OM]. The present Moving Average for the last 50 days of trading for this stock 0.5724, while it was recorded at 0.6507 for the last single week of trading, and 2.4099 for the last 200 days.
Insight into Outset Medical Inc Fundamentals:
Outset Medical Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.04 and a Current Ratio set at 6.49.
OM Stock EPS
With the latest financial reports released by the company, Outset Medical Inc posted -0.59/share EPS, while the average EPS was predicted by analysts to be reported at -0.61/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.02. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Outset Medical Inc go to 23.80%.
Outset Medical Inc [OM] Institutonal Ownership Details
There are presently around $95.97%, or 98.08%% of OM stock, in the hands of institutional investors. The top three institutional holders of OM stocks are: FMR LLC with ownership of 7.7 million shares, which is approximately 15.1214%. AMERIPRISE FINANCIAL INC, holding 5.2 million shares of the stock with an approximate value of $$20.02 million in OM stocks shares; and AMERIPRISE FINANCIAL INC, currently with $$14.69 million in OM stock with ownership which is approximately 7.4955%.
